Corriente Advisors, LLC - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 35 filers reported holding DIAMEDICA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Corriente Advisors, LLC ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$906,000
-88.6%
203,641
-76.6%
0.49%
-83.3%
Q1 2021$7,963,000
-2.7%
870,228
+7.8%
2.93%
+50.5%
Q4 2020$8,182,000
+164.4%
806,900
+10.5%
1.95%
+24.2%
Q3 2020$3,095,000
+121.9%
730,000
+262.7%
1.57%
+73.6%
Q2 2020$1,395,000201,2480.90%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Manatuck Hill Partners, LLC 267,300$1,326,0000.62%
Worth Venture Partners, LLC 132,514$657,0000.36%
WEXFORD CAPITAL LP 400,000$1,984,0000.23%
Eidelman Virant Capital 35,000$173,0000.09%
Granite Point Capital Management, L.P. 229,970$1,141,0000.08%
Patriot Financial Group Insurance Agency, LLC 2,000$10,0000.00%
GABLES CAPITAL MANAGEMENT INC. 125$1,0000.00%
FNY Investment Advisers, LLC 521$2,0000.00%
MILLENNIUM MANAGEMENT LLC 99,340$493,0000.00%
TORONTO DOMINION BANK 48$00.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders